M N Raber - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M N Raber

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factorJ L Abbruzzese, T Madden, S M Sugarman, et al.

Investigational New Drugs|November 1, 1992

Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinomaF V Fossella, R J Winn, P Y Holoye, et al.

Journal of the National Cancer Institute|March 3, 1993

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancerW K Murphy, F V Fossella, R J Winn, et al.

Journal of the National Cancer Institute|December 18, 1991

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancerF A Holmes, R S Walters, R L Theriault, et al.

American Journal of Clinical Oncology|April 1, 1990

Ifosfamide with mesna uroprotection in the management of lung cancerP Y Holoye, B S Glisson, J S Lee, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapyR Perez-Soler, F V Fossella, B S Glisson, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factorJ L Abbruzzese, T Madden, S M Sugarman, et al.

Investigational New Drugs|November 1, 1992

Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinomaF V Fossella, R J Winn, P Y Holoye, et al.

Journal of the National Cancer Institute|March 3, 1993

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancerW K Murphy, F V Fossella, R J Winn, et al.

Journal of the National Cancer Institute|December 18, 1991

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancerF A Holmes, R S Walters, R L Theriault, et al.

American Journal of Clinical Oncology|April 1, 1990

Ifosfamide with mesna uroprotection in the management of lung cancerP Y Holoye, B S Glisson, J S Lee, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapyR Perez-Soler, F V Fossella, B S Glisson, et al.

Pageof 6